Regulus Therapeutics Inc

CUSIP 75915K101COMQ1 2025

Regulus Therapeutics Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

5 filings · latest Mar 25, 2024

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Mar 25, 2024	Ra Capital Management, L.P.	13G	9.5%	6.25M	SEC
2	Mar 18, 2024	Growth Equity Opportunities V, LLC	13D/A	10.0%	6.53M	SEC
3	May 12, 2023	Growth Equity Opportunities V, LLC	13D/A	10.0%	1.95M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Driehaus Capital Management LLC	958.3K	$1.68M